Study of tamoxifen derived perfluoroalkylated olefins in breast cancer treatment Estrogen-responsive breast cancer has been treated with tamoxifen since 1998, yet challenges such as limited selectivity and emerging resistance remai…

Thrilled to share our recent work‼️ We developed perfluoroalkylated tamoxifen derivatives with superior activity in ER+ breast cancer cells vs. 4-OHT Thanks to co-authors #WChaladaj #MaríaArufe @fatimalucio.bsky.social @udc.gal @cicaudc.bsky.social #INIBIC #USC #PolishAcadSciences